Literature DB >> 23400748

An algorithm to detect adverse drug reactions in the neonatal intensive care unit.

Wei Du1, Victoria Tutag Lehr, Mary Lieh-Lai, Winston Koo, Robert M Ward, Michael J Rieder, John N Van Den Anker, Jaxk H Reeves, Merene Mathew, Mirjana Lulic-Botica, Jacob V Aranda.   

Abstract

Critically ill newborns in neonatal intensive care units (NICUs) are at greater risk of developing adverse drug reactions (ADRs). Differentiation of ADRs from reactions associated with organ dysfunction/immaturity is difficult. Current ADR algorithm scoring was established arbitrarily without validation in infants. The study objective was to develop a valid and reliable algorithm to identify ADRs in the NICU. Algorithm development began with a 24-item questionnaire for data collection on 100 previously suspected ADRs. Five pediatric pharmacologists independently rated cases as definite, probable, possible, and unlikely ADRs. Consensus "gold standard" was reached via teleconference. Logistic regression and iterative C programs were used to derive the scoring system. For validation, 50 prospectively collected ADR cases were assessed by 3 clinicians using the new algorithm and the Naranjo algorithm. Weighted kappa and intraclass correlation coefficient (ICC) were used to compare validity and reliability of algorithms. The new algorithm consists of 13 items. Kappa and ICC of the new algorithm were 0.76 and 0.62 versus 0.31 and 0.43 for the Naranjo algorithm. The new algorithm developed using actual patient data is more valid and reliable than the Naranjo algorithm for identifying ADRs in the NICU population. Because of the relatively small and nonrandom samples, further refinement and additional testing are needed.
© 2012 The Author(s).

Entities:  

Mesh:

Year:  2013        PMID: 23400748     DOI: 10.1177/0091270011433327

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  21 in total

1.  Neonates and medicines: a roadmap to further improve neonatal pharmaceutical care.

Authors:  Karel Allegaert; Catherine Sherwin
Journal:  Eur J Pediatr       Date:  2016-01-07       Impact factor: 3.183

2.  Risk of prescribing errors in acutely admitted patients: a pilot study.

Authors:  Dorthe Krogsgaard Bonnerup; Marianne Lisby; Eva Aggerholm Sædder; Charlotte Arp Sørensen; Birgitte Brock; Ljubica Andersen; Anette Gjetrup Eskildsen; Lars Peter Nielsen
Journal:  Int J Clin Pharm       Date:  2016-07-09

3.  Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials.

Authors:  Jonathan M Davis; Gerri R Baer; Susan McCune; Agnes Klein; Junko Sato; Laura Fabbri; Alexandra Mangili; Mary A Short; Susan Tansey; Barry Mangum; Isamu Hokuto; Hidefumi Nakamura; Thomas Salaets; Karel Allegaert; Lynne Yao; Michael Blum; Joseph Toerner; Mark Turner; Ron Portman
Journal:  J Pediatr       Date:  2019-11-08       Impact factor: 4.406

4.  Ranitidine-induced Thrombocytopenia in a Neonate - A Case Report and Review of Literature.

Authors:  Levi Hoste; Isabel George
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Jan-Feb

Review 5.  Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct.

Authors:  Mark A Turner
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

6.  Adverse drug reactions in neonates and infants: a population-tailored approach is needed.

Authors:  Karel Allegaert; Johannes N van den Anker
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

Review 7.  Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay--a systematic review.

Authors:  Lateef Mohiuddin Khan
Journal:  Eur J Clin Pharmacol       Date:  2013-08-17       Impact factor: 2.953

8.  Antihypertensive-related adverse drug reactions among older hospitalized adults.

Authors:  Tariq M Alhawassi; Ines Krass; Lisa G Pont
Journal:  Int J Clin Pharm       Date:  2018-02-01

Review 9.  Clinical pharmacology in neonates: small size, huge variability.

Authors:  Karel Allegaert; John N van den Anker
Journal:  Neonatology       Date:  2014-05-30       Impact factor: 4.035

10.  Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR.

Authors:  Lateef M Khan; Sameer E Al-Harthi; Omar I Saadah
Journal:  Saudi Pharm J       Date:  2012-10-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.